vs
Side-by-side financial comparison of HIVE Digital Technologies Ltd. (HIVE) and PTC THERAPEUTICS, INC. (PTCT). Click either name above to swap in a different company.
PTC THERAPEUTICS, INC. is the larger business by last-quarter revenue ($164.7M vs $93.1M, roughly 1.8× HIVE Digital Technologies Ltd.). PTC THERAPEUTICS, INC. runs the higher net margin — -82.0% vs -98.1%, a 16.1% gap on every dollar of revenue. On growth, HIVE Digital Technologies Ltd. posted the faster year-over-year revenue change (218.6% vs -22.7%). Over the past eight quarters, HIVE Digital Technologies Ltd.'s revenue compounded faster (102.2% CAGR vs -11.5%).
Mastech Digital, Inc. is a digital transformation and information technology (IT) services company headquartered in Pittsburgh, Pennsylvania, providing services to corporations across North America, Middle East, Asian, and Japan.
PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.
HIVE vs PTCT — Head-to-Head
Income Statement — Q3 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $93.1M | $164.7M |
| Net Profit | $-91.3M | $-135.0M |
| Gross Margin | -27.1% | — |
| Operating Margin | — | -43.3% |
| Net Margin | -98.1% | -82.0% |
| Revenue YoY | 218.6% | -22.7% |
| Net Profit YoY | -234.0% | -104.8% |
| EPS (diluted) | $-0.38 | $-1.63 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $93.1M | $164.7M | ||
| Q3 25 | $87.3M | $211.0M | ||
| Q2 25 | $45.6M | $178.9M | ||
| Q1 25 | — | $1.2B | ||
| Q4 24 | $29.2M | $213.2M | ||
| Q3 24 | $22.6M | $196.8M | ||
| Q2 24 | $32.2M | $186.7M | ||
| Q1 24 | — | $210.1M |
| Q4 25 | $-91.3M | $-135.0M | ||
| Q3 25 | $-15.8M | $15.9M | ||
| Q2 25 | $35.0M | $-64.8M | ||
| Q1 25 | — | $866.6M | ||
| Q4 24 | $68.2M | $-65.9M | ||
| Q3 24 | $80.0K | $-106.7M | ||
| Q2 24 | $-18.3M | $-99.2M | ||
| Q1 24 | — | $-91.6M |
| Q4 25 | -27.1% | — | ||
| Q3 25 | 4.7% | — | ||
| Q2 25 | -13.6% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -43.7% | — | ||
| Q3 24 | -66.1% | — | ||
| Q2 24 | -7.4% | — | ||
| Q1 24 | — | — |
| Q4 25 | — | -43.3% | ||
| Q3 25 | — | 1.4% | ||
| Q2 25 | — | -19.5% | ||
| Q1 25 | — | 82.5% | ||
| Q4 24 | — | -76.2% | ||
| Q3 24 | — | -27.7% | ||
| Q2 24 | — | -21.5% | ||
| Q1 24 | — | -21.6% |
| Q4 25 | -98.1% | -82.0% | ||
| Q3 25 | -18.1% | 7.5% | ||
| Q2 25 | 76.8% | -36.3% | ||
| Q1 25 | — | 73.7% | ||
| Q4 24 | 233.2% | -30.9% | ||
| Q3 24 | 0.4% | -54.2% | ||
| Q2 24 | -56.7% | -53.1% | ||
| Q1 24 | — | -43.6% |
| Q4 25 | $-0.38 | $-1.63 | ||
| Q3 25 | $-0.07 | $0.20 | ||
| Q2 25 | $0.18 | $-0.83 | ||
| Q1 25 | — | $10.04 | ||
| Q4 24 | $0.52 | $-0.85 | ||
| Q3 24 | $0.00 | $-1.39 | ||
| Q2 24 | $-0.17 | $-1.29 | ||
| Q1 24 | — | $-1.20 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $1.9B |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $559.3M | $-205.3M |
| Total Assets | $624.0M | $2.9B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $1.9B | ||
| Q3 25 | — | $1.7B | ||
| Q2 25 | — | $2.0B | ||
| Q1 25 | — | $2.0B | ||
| Q4 24 | $40.5M | $1.1B | ||
| Q3 24 | $31.7M | $1.0B | ||
| Q2 24 | — | $1.1B | ||
| Q1 24 | — | $884.8M |
| Q4 25 | $559.3M | $-205.3M | ||
| Q3 25 | $624.6M | $-155.8M | ||
| Q2 25 | $560.5M | $-206.5M | ||
| Q1 25 | — | $-185.8M | ||
| Q4 24 | $430.9M | $-1.1B | ||
| Q3 24 | $275.5M | $-1.1B | ||
| Q2 24 | $268.6M | $-980.2M | ||
| Q1 24 | — | $-893.9M |
| Q4 25 | $624.0M | $2.9B | ||
| Q3 25 | $693.0M | $2.6B | ||
| Q2 25 | $628.7M | $2.6B | ||
| Q1 25 | — | $2.7B | ||
| Q4 24 | $478.6M | $1.7B | ||
| Q3 24 | $334.7M | $1.8B | ||
| Q2 24 | — | $1.9B | ||
| Q1 24 | — | $1.8B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $46.0M | $-34.3M |
| Free Cash FlowOCF − Capex | — | $-36.6M |
| FCF MarginFCF / Revenue | — | -22.3% |
| Capex IntensityCapex / Revenue | — | 1.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $702.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $46.0M | $-34.3M | ||
| Q3 25 | $-10.6M | $-66.3M | ||
| Q2 25 | $10.2M | $-58.3M | ||
| Q1 25 | — | $870.1M | ||
| Q4 24 | $-28.5M | $-30.0M | ||
| Q3 24 | $-2.2M | $-77.0M | ||
| Q2 24 | $-4.4M | $-71.5M | ||
| Q1 24 | — | $70.8M |
| Q4 25 | — | $-36.6M | ||
| Q3 25 | — | $-69.7M | ||
| Q2 25 | — | $-59.6M | ||
| Q1 25 | — | $868.4M | ||
| Q4 24 | $-55.5M | $-33.8M | ||
| Q3 24 | $-34.7M | $-77.5M | ||
| Q2 24 | — | $-78.8M | ||
| Q1 24 | — | $61.2M |
| Q4 25 | — | -22.3% | ||
| Q3 25 | — | -33.1% | ||
| Q2 25 | — | -33.3% | ||
| Q1 25 | — | 73.8% | ||
| Q4 24 | -189.9% | -15.8% | ||
| Q3 24 | -153.4% | -39.4% | ||
| Q2 24 | — | -42.2% | ||
| Q1 24 | — | 29.1% |
| Q4 25 | — | 1.4% | ||
| Q3 25 | — | 1.6% | ||
| Q2 25 | — | 0.7% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | 92.5% | 1.8% | ||
| Q3 24 | 143.9% | 0.3% | ||
| Q2 24 | — | 4.0% | ||
| Q1 24 | — | 4.6% |
| Q4 25 | — | — | ||
| Q3 25 | — | -4.17× | ||
| Q2 25 | 0.29× | — | ||
| Q1 25 | — | 1.00× | ||
| Q4 24 | -0.42× | — | ||
| Q3 24 | -26.94× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
